First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - VERTEX PHARMACEUTICALS (EUROPE) LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: VERTEX PHARMACEUTICALS (EUROPE) LIMITED, 2 KINGDOM STREET, LONDON, W2 6BD. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 11 March 1994.

The accounts next due date is 30 September 2024. There are no mortgages.

The above was based on public record information as at 28 October 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 02907620
Date Incorporated: 11 March 1994
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 02907620
Annual Return: 11 March 2016
Registered Office: 2 KINGDOM STREET, LONDON, W2 6BD
SIC Code and Operations: 72190
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

VERTEX PHARMACEUTICALS (EUROPE) LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 7 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
07643914 VERTEX PHARMACEUTICALS (U.K.) LIMITED Active
12387733 VERTEX PINNACLE INVESTMENTS LTD Active
14885400 VERTEX PLANT HIRE LTD Active - Proposal to Strike off
14965724 VERTEX PLANT LIMITED Active
11366768 VERTEX PLANT MAINTENANCE LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd